Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
PX Stock Summary
Top 10 Correlated ETFs
PX
In the News
7 Hypergrowth Stocks With Double-Your-Money Potential
Many investors are looking for companies that can deliver outsized returns. That's why hypergrowth stocks remain attractive, especially ones with the potential to double your investment.
P10, Inc. (PX) Q4 2023 Earnings Call Transcript
P10, Inc. (NYSE:PX) Q4 2023 Earnings Conference Call February 29, 2024 5:00 PM ET
Compared to Estimates, P10, Inc. (PX) Q4 Earnings: A Look at Key Metrics
Although the revenue and EPS for P10, Inc. (PX) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
P10, Inc. (PX) Q4 Earnings Meet Estimates
P10, Inc. (PX) came out with quarterly earnings of $0.21 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.22 per share a year ago.
Earnings Preview: P10, Inc. (PX) Q4 Earnings Expected to Decline
P10, Inc. (PX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
P10 Schedules Fourth Quarter and Full Year 2023 Earnings Release for Thursday, February 29, 2024
DALLAS, Feb. 07, 2024 (GLOBE NEWSWIRE) -- P10, Inc. (NYSE: PX), a leading private markets solutions provider, today announced it will release its fourth quarter and full year 2023 results on Thursday, February 29, 2024, after U.S. markets close.
P10: I Expect Shares To Double Over The Next 3 Years
P10 shares have underperformed the market due to a slowdown in organic growth, decline in EBITDA margins, and lack of acquisitions. P10's stability of revenue and free cash flow, niche focus on small and mid-market private equity, and an improved outlook for private equity fundraising make the company an attractive business. P10 shares trade at less than 11x my estimate of current free cash flow and I believe shares can double looking out three years.
P10, Inc. (PX) Q3 2023 Earnings Call Transcript
P10, Inc. (NYSE:PX ) Q3 2023 Earnings Conference Call November 9, 2023 5:00 PM ET Company Participants Mark Hood – Executive Vice President-Operations and Investor Relations Robert Alpert – Executive Chairman Clark Webb – Executive Vice Chairman Luke Sarsfield – Chief Executive Officer Fritz Souder – Chief Operating Officer Amanda Coussens – Chief Financial Officer Conference Call Participants Kenneth Worthington – JPMorgan Mike Brown – KBW Ben Budish – Barclays Michael Cyprys – Morgan Stanley John Campbell – Stephens Inc. Adam Beatty – UBS Operator Hello and welcome to the P10 Third Quarter 2023 Conference Call. My name is Latif and I will be coordinating your call today.
P10, Inc. (PX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for P10, Inc. (PX) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
P10 Schedules Third Quarter 2023 Earnings Release for Thursday, November 9, 2023
DALLAS, Oct. 24, 2023 (GLOBE NEWSWIRE) -- P10, Inc. (NYSE: PX), a leading private markets solutions provider, today announced it will release its third quarter 2023 results on Thursday, November 9, 2023, after U.S. markets close.
PX Financial details
PX Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.38 | 0.58 | 1.34 | 1.7 | 2.08 | |
Net income per share | 0.1 | 0.2 | 0.1 | 0.25 | -0.06 | |
Operating cash flow per share | 0.14 | 0.09 | 0.44 | 0.53 | 0.41 | |
Free cash flow per share | 0.14 | 0.09 | 0.43 | 0.52 | 0.4 | |
Cash per share | 0.16 | 0.1 | 0.36 | 0.19 | 0.28 | |
Book value per share | 0.31 | 0.51 | 3.52 | 3.37 | 3.32 | |
Tangible book value per share | -0.99 | -3.87 | -1.36 | -1.92 | -1.76 | |
Share holders equity per share | 0.31 | 0.51 | 3.52 | 3.37 | 3.32 | |
Interest debt per share | 1.4 | 2.64 | 2.23 | 2.88 | 2.72 | |
Market cap | 1.42B | 1.42B | 1.57B | 1.25B | 1.19B | |
Enterprise value | 1.55B | 1.7B | 1.76B | 1.53B | 1.46B | |
P/E ratio | 118.52 | 59.45 | 145.85 | 42.65 | -166.35 | |
Price to sales ratio | 31.52 | 21.01 | 10.43 | 6.28 | 4.91 | |
POCF ratio | 84.18 | 132.64 | 32.04 | 20.2 | 24.88 | |
PFCF ratio | 84.33 | 133.06 | 32.14 | 20.69 | 25.68 | |
P/B Ratio | 39.27 | 23.65 | 3.97 | 3.17 | 3.08 | |
PTB ratio | 39.27 | 23.65 | 3.97 | 3.17 | 3.08 | |
EV to sales | 34.5 | 25.25 | 11.68 | 7.73 | 6.06 | |
Enterprise value over EBITDA | 66.21 | 70.12 | 23.27 | 20.52 | 27.67 | |
EV to operating cash flow | 92.13 | 159.44 | 35.86 | 24.86 | 30.72 | |
EV to free cash flow | 92.29 | 159.95 | 35.97 | 25.47 | 31.69 | |
Earnings yield | 0.01 | 0.02 | 0.01 | 0.02 | -0.01 | |
Free cash flow yield | 0.01 | 0.01 | 0.03 | 0.05 | 0.04 | |
Debt to equity | 4.23 | 4.98 | 0.58 | 0.83 | 0.76 | |
Debt to assets | 0.75 | 0.51 | 0.34 | 0.39 | 0.35 | |
Net debt to EBITDA | 5.72 | 11.79 | 2.48 | 3.85 | 5.25 | |
Current ratio | 0.19 | 0.06 | 2.18 | 2.18 | 0.86 | |
Interest coverage | 1.13 | 0.74 | 1.82 | 4.57 | 1.05 | |
Income quality | 1.41 | 0.45 | 4.55 | 2.1 | -6.69 | |
Dividend Yield | 0 | 0 | 0 | 0.01 | 0.01 | |
Payout ratio | 0 | 0 | 0.21 | 0.36 | -2.08 | |
Sales general and administrative to revenue | 0.48 | 0.64 | 0.51 | 0.63 | 0.15 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.75 | 0.88 | 0.81 | 0.8 | 0.75 | |
Capex to operating cash flow | 0 | 0 | 0 | -0.02 | -0.03 | |
Capex to revenue | 0 | 0 | 0 | -0.01 | -0.01 | |
Capex to depreciation | 0 | 0 | -0.01 | -0.05 | -0.05 | |
Stock based compensation to revenue | 0.01 | 0.01 | 0.03 | 0.09 | 0.14 | |
Graham number | 0.84 | 1.53 | 2.75 | 4.35 | 2.14 | |
ROIC | 0.55 | -0.19 | 0.18 | 0.05 | 0.08 | |
Return on tangible assets | 0.24 | 0.35 | 0.08 | 0.17 | -0.03 | |
Graham Net | -1.25 | -4.25 | -1.74 | -2.8 | -2.7 | |
Working capital | -96.98M | -266.41M | 33.17M | 47.07M | -18.89M | |
Tangible asset value | -116.1M | -453.88M | -152.33M | -224.55M | -204.07M | |
Net current asset value | -144.69M | -504.64M | -219.81M | -305.67M | -292.78M | |
Invested capital | 4.23 | 4.98 | 0.58 | 0.83 | 0.76 | |
Average receivables | 0 | 3.88M | 11.46M | 37.54M | 70.7M | |
Average payables | 0 | 604.5K | 752K | 1.49M | 2.04M | |
Average inventory | 0 | 9.48M | 41.38M | 31.91M | 0.5 | |
Days sales outstanding | 21.18 | 27.96 | 43.07 | 105.47 | 126.94 | |
Days payables outstanding | 3.24 | 16.91 | 2.67 | 9.98 | 3.53 | |
Days of inventory on hand | 0 | 290.5 | 425.37 | 0 | 0 | |
Receivables turnover | 17.24 | 13.05 | 8.47 | 3.46 | 2.88 | |
Payables turnover | 112.51 | 21.59 | 136.55 | 36.58 | 103.34 | |
Inventory turnover | 11.93M | 1.26 | 0.86 | 94.3M | 0 | |
ROE | 0.33 | 0.4 | 0.03 | 0.07 | -0.02 | |
Capex per share | 0 | 0 | 0 | -0.01 | -0.01 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.5 | 0.46 | 0.5 | 0.51 | 0.54 | |
Net income per share | 0.04 | 0 | 0.01 | -0.07 | -0.01 | |
Operating cash flow per share | 0.15 | 0.17 | 0.07 | 0.14 | 0.02 | |
Free cash flow per share | 0.15 | 0.16 | 0.07 | 0.14 | 0.01 | |
Cash per share | 0.19 | 0.2 | 0.19 | 0.17 | 0.28 | |
Book value per share | 3.39 | 3.14 | 3.18 | 3.33 | 3.32 | |
Tangible book value per share | -1.94 | -1.78 | -1.69 | -1.8 | -1.76 | |
Share holders equity per share | 3.39 | 3.14 | 3.18 | 3.33 | 3.32 | |
Interest debt per share | 2.85 | 3.12 | 2.94 | 2.48 | 2.58 | |
Market cap | 1.24B | 1.25B | 1.4B | 1.35B | 1.19B | |
Enterprise value | 1.52B | 1.53B | 1.67B | 1.62B | 1.46B | |
P/E ratio | 66.58 | 517.72 | 198.49 | -40.23 | -273.39 | |
Price to sales ratio | 21.19 | 21.88 | 22.41 | 22.97 | 18.81 | |
POCF ratio | 69.74 | 60.3 | 166.05 | 81.57 | 631.8 | |
PFCF ratio | 71.36 | 61.83 | 173.67 | 82.37 | 816.6 | |
P/B Ratio | 3.15 | 3.22 | 3.55 | 3.5 | 3.08 | |
PTB ratio | 3.15 | 3.22 | 3.55 | 3.5 | 3.08 | |
EV to sales | 26.12 | 26.78 | 26.72 | 27.43 | 23.22 | |
Enterprise value over EBITDA | 100.52 | 116.35 | 95.53 | 250.66 | 110.45 | |
EV to operating cash flow | 85.97 | 73.81 | 198.03 | 97.39 | 779.86 | |
EV to free cash flow | 87.97 | 75.68 | 207.12 | 98.35 | 1.01K | |
Earnings yield | 0 | 0 | 0 | -0.01 | 0 | |
Free cash flow yield | 0.01 | 0.02 | 0.01 | 0.01 | 0 | |
Debt to equity | 0.83 | 0.98 | 0.91 | 0.73 | 0.76 | |
Debt to assets | 0.39 | 0.46 | 0.44 | 0.35 | 0.35 | |
Net debt to EBITDA | 18.98 | 21.29 | 15.43 | 40.71 | 20.97 | |
Current ratio | 2.18 | 2.2 | 2.37 | 0.98 | 0.86 | |
Interest coverage | 1.37 | 0.94 | 1.9 | 0.07 | 0.99 | |
Income quality | 3.67 | 27.02 | 4.01 | -1.9 | -1.73 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0.75 | 5.75 | 2.32 | -0.47 | -3.5 | |
Sales general and administrative to revenue | 0.75 | 0.77 | 0.71 | 0.86 | 0.16 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.8 | 0.78 | 0.79 | 0.78 | 0.75 | |
Capex to operating cash flow | -0.02 | -0.02 | -0.04 | -0.01 | -0.23 | |
Capex to revenue | -0.01 | -0.01 | -0.01 | 0 | -0.01 | |
Capex to depreciation | -0.05 | -0.07 | -0.05 | -0.02 | -0.06 | |
Stock based compensation to revenue | 0.12 | 0.12 | 0.13 | 0.06 | 0.25 | |
Graham number | 1.75 | 0.59 | 1.01 | 2.33 | 0.84 | |
ROIC | 0.02 | -0.03 | 0.01 | 0 | 0.23 | |
Return on tangible assets | 0.03 | 0 | 0.01 | -0.05 | -0.01 | |
Graham Net | -2.82 | -2.24 | -2.5 | -2.23 | -2.7 | |
Working capital | 47.07M | 53.95M | 54.03M | -2M | -18.89M | |
Tangible asset value | -224.55M | -220.81M | -208.81M | -209.01M | -204.07M | |
Net current asset value | -305.67M | -305.4M | -291.19M | -287.99M | -292.78M | |
Invested capital | 0.83 | 0.98 | 0.91 | 0.73 | 0.76 | |
Average receivables | 48.54M | 60.14M | 65.79M | 72.8M | 80.53M | |
Average payables | 2.24M | 2.81M | 2.89M | 2.43M | 1.8M | |
Average inventory | -1.8M | 54.81M | 54.81M | 50.69M | 50.69M | |
Days sales outstanding | 88.42 | 98.97 | 98.85 | 117.56 | 119.97 | |
Days payables outstanding | 2.46 | 7.67 | 6.8 | 4.5 | 3.35 | |
Days of inventory on hand | 0 | 276.82 | 0 | 216.36 | 0 | |
Receivables turnover | 1.02 | 0.91 | 0.91 | 0.77 | 0.75 | |
Payables turnover | 36.58 | 11.73 | 13.23 | 20.02 | 26.9 | |
Inventory turnover | 94.3M | 0.33 | 36.31M | 0.42 | 0 | |
ROE | 0.01 | 0 | 0 | -0.02 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
PX Frequently Asked Questions
What is P10, Inc. stock symbol ?
P10, Inc. is a US stock , located in Dallas of Tx and trading under the symbol PX
Is P10, Inc. buy or a sell ?
1 stock analysts have 1 predictions with a medium analyst target price of $16. The lowest prediction is $16 and the highest is $16
What is PX stock prediction ?
What is P10, Inc. stock quote today ?
P10, Inc. stock price is $8.38 today.
Is P10, Inc. stock public?
Yes, P10, Inc. is a publicly traded company.